Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the Cytosorbents fourth quarter and 2025 full-year earnings conference call. At this time, all lines are in the listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star 0 for the operator. This call is being recorded on Wednesday, March 25, 2026. I would now like to turn the conference over to Pete Moriani, Chief Financial Officer. Please go ahead. Thank you, Vincent. Good afternoon, everyone. Welcome to CITUS Orbit's fourth quarter and full year 2025 conference call. Joining me today is Dr. Philip Chan, our Chief Executive Officer. Before I turn the call over to Phil, I'd like to remind listeners that during the call, management's prepared remarks may contain forward-looking statements. which are subject to risks and uncertainties. Management may make additional forward-looking statements in response to your questions. Therefore, the company claims protection under the Safe Harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results may differ from results discussed today. The forward-looking statements we make may reflect our views and estimates as of today, March 25, 2026, And we assume no obligation to update these projections in the future as market conditions change. We encourage investors to review the risks discussed in our annual report on Form 10-K, filed with the SEC on March 31, 2025, and as updated on risks reported in our quarterly reports on Form 10-Q and in press releases and other communications to shareholders issued from time to time. During today's call, we will have an overview presentation covering the operating fina...